Gamma-glutamyl transferase: a potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction-associated steatotic liver disease

This study demonstrates clinical benefits of combining imaging markers with blood markers, such as GGT, in patients without a history of pancreatitis who have obesity and MASLD. Pairing LiverMultiScan with standard blood markers enables early identification and risk stratification of fatty pancreas in individuals with MASLD.